Get the Stockscreener App
9.70
1.89%
0.18
Xencor Inc stock is traded at $9.70, with a volume of 614.27K.
It is up +1.89% in the last 24 hours and down -25.27% over the past month.
Xencor Inc a clinical-stage biopharmaceutical company focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases. The company uses its XmAb technology platform to create antibody product candidates. Its pipeline includes XmAb819, XmAb541, XmAb808, XmAb942, Plamotamab, and XmAb657. The group earns its revenue from collaboration agreements, product licensing agreements, and technology licensing agreements.
See More
Previous Close:
$9.52
Open:
$9.47
24h Volume:
614.27K
Relative Volume:
0.89
Market Cap:
$629.93M
Revenue:
$133.62M
Net Income/Loss:
$-177.37M
P/E Ratio:
-3.3564
EPS:
-2.89
Net Cash Flow:
$23.50M
1W Performance:
+22.47%
1M Performance:
-25.27%
6M Performance:
-54.59%
1Y Performance:
-49.13%
1-Day Range:
$9.315
$9.76
1-Week Range:
$7.57
$10.00
52-Week Range:
$7.16
$27.24
Xencor Inc Stock (XNCR) Company Profile
Name
Xencor Inc
Sector
Industry
Phone
626-305-5900
Address
465 N. HALSTEAD ST., PASADENA, CA
Compare XNCR with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
XNCR
Xencor Inc
|
9.70 | 629.93M | 133.62M | -177.37M | 23.50M | -2.89 |
|
VRTX
Vertex Pharmaceuticals Inc
|
489.10 | 127.47B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.16 | 62.43B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
596.20 | 37.03B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
234.56 | 31.06B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
230.98 | 26.16B | 3.81B | -644.79M | -669.77M | -6.24 |
Xencor Inc Stock (XNCR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-12-24 | Initiated | Wells Fargo | Overweight |
| Dec-02-24 | Upgrade | Piper Sandler | Neutral → Overweight |
| Apr-16-24 | Reiterated | BTIG Research | Buy |
| Feb-28-24 | Downgrade | Piper Sandler | Overweight → Neutral |
| May-19-23 | Initiated | BofA Securities | Buy |
| Dec-06-22 | Initiated | Cowen | Outperform |
| Oct-13-22 | Upgrade | Raymond James | Outperform → Strong Buy |
| Sep-21-22 | Initiated | JP Morgan | Overweight |
| Jul-06-22 | Resumed | Canaccord Genuity | Buy |
| Feb-11-22 | Initiated | BMO Capital Markets | Outperform |
| Jan-21-22 | Initiated | SMBC Nikko | Outperform |
| Dec-15-21 | Initiated | H.C. Wainwright | Buy |
| Oct-15-21 | Resumed | BTIG Research | Buy |
| Feb-24-21 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Mar-04-20 | Initiated | Barclays | Underweight |
| Feb-25-20 | Upgrade | Guggenheim | Neutral → Buy |
| Jan-30-20 | Initiated | RBC Capital Mkts | Outperform |
| Nov-20-19 | Resumed | Guggenheim | Neutral |
| Aug-07-19 | Downgrade | Guggenheim | Buy → Neutral |
| Aug-07-19 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Jun-13-19 | Initiated | Mizuho | Buy |
| Apr-12-19 | Initiated | Guggenheim | Buy |
| Mar-27-19 | Initiated | Berenberg | Buy |
| Mar-15-19 | Initiated | Raymond James | Outperform |
| Sep-10-18 | Resumed | BTIG Research | Buy |
| Mar-28-18 | Resumed | Leerink Partners | Outperform |
| Mar-02-17 | Initiated | Instinet | Neutral |
| Mar-02-17 | Reiterated | Wedbush | Outperform |
| Oct-04-16 | Initiated | Piper Jaffray | Overweight |
| Dec-22-15 | Initiated | Canaccord Genuity | Buy |
| Aug-05-15 | Reiterated | MLV & Co | Buy |
| Feb-12-15 | Reiterated | Oppenheimer | Outperform |
| Jan-28-15 | Reiterated | MLV & Co | Buy |
| Jul-11-14 | Initiated | Oppenheimer | Outperform |
View All
Xencor Inc Stock (XNCR) Latest News
Xencor, Inc. (NASDAQ:XNCR) Given Consensus Rating of “Buy” by Analysts - Defense World
Xencor, Inc. (NASDAQ:XNCR) Shares Sold by Alliancebernstein L.P. - Defense World
Geode Capital Management LLC Acquires 179,526 Shares of Xencor, Inc. (NASDAQ:XNCR) - Defense World
Wellington Management Group LLP Purchases Shares of 27,491 Xencor, Inc. (NASDAQ:XNCR) - The AM Reporter
27,491 Shares in Xencor, Inc. (NASDAQ:XNCR) Acquired by Wellington Management Group LLP - Defense World
Xencor CFO Cornelissen sells $30,232 in company stock By Investing.com - Investing.com India
Xencor CFO sells $30,232 in company stock - Investing.com
Xencor CFO Cornelissen sells $30,232 in company stock - Investing.com
Xencor (NASDAQ:XNCR) Sets New 1-Year LowHere's Why - MarketBeat
Xencor, Inc.: No Major Near Term Catalysts (NASDAQ:XNCR) - Seeking Alpha
Xencor (XNCR) Upgraded to Buy: Here's Why - Yahoo Finance
Federal Circuit’s Xencor Decision: Considerations for Jepson Claims and Implications for 35 U.S.C. § 101 Analysis - NatLawReview.com
Xencor’s SWOT analysis: biotech stock faces pivotal year ahead By Investing.com - Investing.com Canada
Xencor’s SWOT analysis: biotech stock faces pivotal year ahead - Investing.com India
American Century Companies Inc. Has $2.63 Million Position in Xencor, Inc. (NASDAQ:XNCR) - Defense World
Xencor, Inc. (NASDAQ:XNCR) Shares Bought by Vanguard Group Inc. - Defense World
KLP Kapitalforvaltning AS Invests $280,000 in Xencor, Inc. (NASDAQ:XNCR) - Defense World
Xencor, Inc. (NASDAQ:XNCR) Shares Bought by Prudential Financial Inc. - Defense World
Corebridge Financial Inc. Has $826,000 Position in Xencor, Inc. (NASDAQ:XNCR) - Defense World
Xencor stock hits 52-week low at $9.34 amid market challenges - Investing.com
Xencor stock hits 52-week low at $9.34 amid market challenges By Investing.com - Investing.com South Africa
End of the Road for Jepson Format Claims in the Life Sciences? - JD Supra
Teacher Retirement System of Texas Has $428,000 Stock Holdings in Xencor, Inc. (NASDAQ:XNCR) - Defense World
Xencor, Inc. (NASDAQ:XNCR) Shares May Have Slumped 27% But Getting In Cheap Is Still Unlikely - simplywall.st
Raymond James Financial Inc. Acquires New Holdings in Xencor, Inc. (NASDAQ:XNCR) - Defense World
Xencor, Inc. (NASDAQ:XNCR) Shares Bought by Swiss National Bank - Defense World
Even Jepson Preambles Require Written Description Support - The National Law Review
PNC Financial Services Group Inc. Raises Holdings in Xencor, Inc. (NASDAQ:XNCR) - Defense World
Xencor stock touches 52-week low at $12.53 amid market challenges By Investing.com - Investing.com South Africa
Xencor stock touches 52-week low at $12.53 amid market challenges - Investing.com India
Xencor, Inc. (NASDAQ:XNCR) Receives Average Recommendation of “Buy” from Brokerages - Defense World
When (XNCR) Moves Investors should Listen - news.stocktradersdaily.com
Charles Schwab Investment Management Inc. Boosts Stock Holdings in Xencor, Inc. (NASDAQ:XNCR) - Armenian Reporter
Charles Schwab Investment Management Inc. Purchases 3,652 Shares of Xencor, Inc. (NASDAQ:XNCR) - Defense World
Amundi Acquires 24,494 Shares of Xencor, Inc. (NASDAQ:XNCR) - Defense World
US Bancorp DE Reduces Stock Position in Xencor, Inc. (NASDAQ:XNCR) - Defense World
Bank of New York Mellon Corp Purchases 18,586 Shares of Xencor, Inc. (NASDAQ:XNCR) - Defense World
Federal Circuit Rules Jepson Claims Need Full Written Description: Another Nail in the Coffin - Patently-O
Xencor (NASDAQ:XNCR) Stock Rating Lowered by StockNews.com - Defense World
Fed. Circ. Dings Antibody Patent App For Lacking Description - Law360
Xencor Appoints Todd Simpson To Board Of Directors -March 13, 2025 at 05:31 pm EDT - Marketscreener.com
Xencor Appoints Todd Simpson to Board of Directors - sharewise
Xencor Strengthens Board with Veteran Biotech CFO Behind Seagen's Multi-Billion Success - StockTitan
Xencor’s SVP sells $78,047 in stock By Investing.com - Investing.com India
Xencor’s EVP Nancy Valente sells $34,876 in stock By Investing.com - Investing.com Canada
Antibody Humanization Market Critical Analysis with Expert Opinion: Genentech, Adimab, Xencor - openPR
Xencor Sr. vice president sells $131,851 in shares By Investing.com - Investing.com Australia
Xencor stock touches 52-week low at $13.2 amid market challenges - Investing.com Australia
Xencor Inc Stock (XNCR) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.51%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):